VR Logo

Standard Medical & Pharmaceuticals: Board Meeting-Outcome of Board Meeting

We would like to inform you that the Board of Directors at its meeting held on 14.02.2018, has inter-alia transacted the following business:

1.Considered and approved the unaudited financial results of the company for the Quarter and nine months period ended December 31, 2017 as recommended by the Audit Committee and taken on record together with the Limited Review Report of the Statutory Auditors for the quarter ended on that date.